Medtronic plc filed a Form 8-K with the U.S. Securities and Exchange Commission on September 1, 2026, announcing its first quarter fiscal year 2027 financial results via a press release furnished as an exhibit.
Key Highlights
- Filing date: The current report was filed and dated September 1, 2026.
- Results period: The disclosure covers Medtronic's first quarter of fiscal year 2027.
- Reporting item: The filing was made under Item 2.02, Results of Operations and Financial Condition.
- Press release furnished: A press release dated September 1, 2026 was furnished as Exhibit 99.1.
- Signatory: The report was signed by Thierry Piéton, Executive Vice President and Chief Financial Officer (Principal Financial Officer).
- Registrant: Medtronic plc is a public limited company organized under the laws of Ireland.
Medtronic's First Quarter Fiscal 2027 Results Announcement via 8-K
Medtronic plc (NYSE:MDT) filed a current report on September 1, 2026, disclosing that it had issued a press release on the same date announcing its first quarter fiscal year 2027 financial results. According to the filing, the press release was furnished - not filed - as Exhibit 99.1, consistent with Item 2.02 of Form 8-K, which covers Results of Operations and Financial Condition.
The filing does not itself contain the financial figures from the quarterly results; those details are contained within the press release furnished as Exhibit 99.1. The registrant described itself as "a public limited company organized under the laws of Ireland," with its principal executive offices located at Building Two, Parkmore Business Park West, Galway, Ireland. Medtronic's ordinary shares trade on the New York Stock Exchange under the symbol MDT, and the company also has numerous series of Senior Notes registered on the same exchange under various trading symbols.
The report was signed by Thierry Piéton in his capacity as Executive Vice President and Chief Financial Officer (Principal Financial Officer). The filing also included a Cover Page Interactive Data File as Exhibit 104, embedded with the Inline XBRL document. No financial figures, revenue figures, or earnings details are presented within the 8-K body itself, as the substantive results are contained solely in the furnished exhibit.
What Was Disclosed
Medtronic plc filed an 8-K on September 1, 2026 under Item 2.02, furnishing a press release as Exhibit 99.1 to announce first quarter fiscal year 2027 financial results. The filing was signed by CFO Thierry Piéton.




Please wait processing your request...